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Abstract
OBJECTIVE: To evaluate the protection of Danshen
(Radix Salviae Miltiorrhizae) (SM) injection in myo-
cardial infarction (MI) induced renal damage.
METHODS: Forty male C57 mice were divided into
control group, MI group and SM group. In MI
group, the left coronary artery was occluded for 8
weeks; the same procedure was used for the SM
group, with the additional step of SM (0.2 mL) ad-
ministered intraperitoneally for 56 days. Before sur-
gery and 8 weeks later, transthoracic echocardiog-
raphy was performed and urine protein and albu-
min was measured. At the end of the time, all mice
were killed and kidneys removed for reactive oxy-
gen species (ROS) and fibrosis analysis, plasma was
collected for blood urea nitrogen and serum creati-
nine determination.
RESULTS: MI slightly decreased renal function and
increased production of ROS, accompanied with re-
nal fibrosis. Administration of SM reduced produc-
tion of ROS and increased renal function, it also re-
duced renal fibrosis.
CONCLUSION: MI plays a causal role in renal injury
and SM exerts renal-protective effects, probably by
its antioxidant activities.
© 2015 JTCM. All rights reserved.
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INTRODUCTION
Heart failure (HF) is a complex syndrome character-
ized by signs related to inadequate perfusion of organs
and tissues during exercise and represents the common
pathway for most primary cardiovascular diseases.1 Pro-
gressive aging of the population, together with the sig-
nificant reduction in mortality for cardiovascular diseas-
es, have been accompanied by a marked increase in its
prevalence, so that HF is now considered a major pub-
lic health problem2
Myocardial infarction (MI) patient's progressed to very
late stage will cause chronic heart failure. Chronic
heart failure with renal insufficiency, which means car-
diorenal syndrome, has gradually attracted attention of
the medications.3 As we all know, congestive heart fail-
ure is a progressive disorder that in its later stages leads
to intense intrarenal vasoconstriction, elevated renal
vascular resistance, reduced renal blood flow,4 progres-
sive kidney damage and renal insufficiency.5 Recently,
excessive production of reactive oxygen species (ROS)
has been found to be involved in causing renal injury.
In recent years, the incidence of chronic cardiovascular
disease was significantly higher, and due to the surgical
treatment of many patients in the acute phase of the
disease, the progression of the disease to end-stage pa-
tients also increased significantly, which often present
306
JTCM |www. journaltcm. com June 15, 2015 |Volume 35 | Issue 3 |
Lu XM et al. / Experimental Study
with renal insufficiency and cardiorenal syndrome man-
ifestations.
Traditional Chinese Medicine has evolved into a
well-developed, coherent system of medicine to treat ill-
ness.6 Herbal medicine has been used for more than
2000 years.7 Danshen (Radix Salviae Miltiorrhizae)
(SM) is a kind of traditional chinese drug commonly
used for activating circulation,8 the research on the eﬀ
ect of it in the treatment of cardiorenal syndrome has
not been reported. SM injection is the extraction of
wild Salvia roots, the main activating redients include
Danshensu, salvianolic acid, as well as tanshinone, di-
hydrotanshinone, and cryptotanshinone,9 which are
able to protect endothelial cells, ﬁght against inﬂamma-
tion, and prevent lipid peroxidation and calcium over-
load.10-12 Some studies have shown that SM is used to
treat kidney damage through protecting renal cortex
and renal function.13,14 Moreover, SM also shows some
therapeutic eﬀects on renal failure patients.15 Although
SM has been used to treat some kind of renal disease,
the exact mechanism is not very clear. For this reason,
the purpose of this study is to evaluate the protection
of SM injection against chronic heart failure induced
renal failure in mice through observing the pathologi-
cal alterations and the contents of ROS in the kidney.
MATERIALS ANDMETHODS
Animal preparation
Forty male C57 mice of specific pathogen free (SPF)
grade, ten weeks old, weighing (20 ± 3) g, were sup-
plied by China Medical University Animal Center.
Mice were housed under climate-controlled conditions
with a 12-h light/dark cycle and were provided with
standard food and water ad libitum. All experimental
procedures were performed under the guidelines for
the care and use of animals as established by the animal
ethics committee in China Medical University. Mice
were randomly divided into 3 groups by random num-
ber table method, sham group (n = 13), MI group (n =
14), and SM treatment group (n = 13). The surgical
protocol were performed similar to methods described
previously,16 Briefly, the mice were anesthesiaed by
50 mg/kg phenobarbital sodium (Sigma, St. Louis,
MO, USA) to relieve the suffering of the animal, then
the mice were orally intubated with polyethylene tub-
ing and connected to a rodent ventilator (type 845,
Harvard Apparatus, Kent, UK). Positive-pressure artifi-
cial respiration was started immediately with room air,
using a volume of 1.5 mL/100 g body weight at a rate
of 90 strokes/min to maintain normal PCO2, PO2, and
pH parameters. The chest was opened by a left thora-
cotomy, followed by sectioning the fourth and fifth
ribs. The left anterior descending coronary artery was
visualized and ligated with 7-0 silk suture. The chest
wall was closed and allowed to recover in a temperature
controlled area. Mice were included in the MI group if
there was a transmural left ventricular scar at autopsy
obliterating at least 25% of the left ventricular muscle.
Sham-operated mice underwent the same surgery mi-
nus the coronary artery ligation. As for the SM treat-
ment group, mice were treated with 0.2 mL SM injec-
tion (each 10 mL vial contains active components
equivalent to 15 g of the original medicine (Shenghe
Pharmaceutical Co., Ltd., Sichuan, China) intraperito-
neally for 8 weeks. The sham group and MI group
were treated with 0.2 mL saline injection intraperitone-
ally for 8 weeks.
Heart rate, blood pressure and cardiac function
determination
One day before the animals were killed, intelligent
non-invasive blood pressure monitor (Kent Scientific
Corporation, Torrington, CT, USA) were used to mea-
sure systolic blood pressure (SBP) and heart rate (HR)
in the awake state. Transthoracic echocardiography was
performed before surgery and 8 weeks later. Using
HP5500 imaging system (Hewlett-Packard Co., Palo
Alto, CA, USA), equipped with a 15 MHz probe. The
M-mode cursor was positioned perpendicular to the an-
terior wall in order to measure interventricular septal
thickness (IVS), left ventricular end-diastolic and
end-systolic diameters (LVDD and LVDS, respective-
ly) at the level of the papillary muscles below the mitral
valve tip, and LV ejection fraction (EF) and fractional
shortening (FS) were calculated.
BUN, SCr, urinary protein and albumin
concentrations determination
After decapitation, trunk blood was collected into
chilled tubes and processed for measurements of plas-
ma BUN and SCr (Nanjing jiancheng company, Nan-
jing, China). The urinary excretion rate of protein and
albumin concentration was measured using ELISA kit
(Exocell Inc., Philadelphia, PA, USA) from a one day
timed urine collection on 8 weeks after surgery.
SOD, MDA and ROS determination
Coomassie brilliant blue method17 was used for the de-
termination of protein content, using the xanthine oxi-
dation method18 and thiobarbituric acid (TAB, Sig-
ma-Aldrich, St. Louis, MO, USA) to determine the ac-
tivity of Superoxide dismutase (SOD) and the contents
of malondiadehyde (MDA) and ROS according to kits
instructions (Nanjing jiancheng company, Nanjing,
China).
Renal pathological changes
The animals were killed by decapitation, followed by
immediate organ collection for histologic analysis.
Fresh kidney sections were fixed in 10% buffered for-
malin (Sigma-Aldrich, St. Louis, MO, USA) and em-
bedded in paraffin (Sigma-Aldrich, St. Louis, MO,
USA), 4 μm sections were stained with hematoxy-
lin-eosin (HE) and azo-carmine G and aniline blue
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(AZAN) staining by light microscopy. A pathologist
blind to group assignments analyzed the samples and
determined the levels of injury.
TGF-β, CTGF, COLⅠand COLⅢ expression in
kidney tissues
The mRNA expression of glyceraldehydes-3-phosphate-
dehydrogenase (GAPDH), transforming growth fac-
tor-β (TGF-β), connective tissue growth factor (CT-
GF), collagen Ⅰ (COLⅠ) and collagen Ⅲ (COLⅢ)
were analyzed by real-time reverse transcription–poly-
merase chain reaction using a Light Cycler Fast Start
DNA Master SYBR Green I kit (Applied Biosystems,
Foster City, CA, USA). The primer sequences are as fol-
lows: 5′ GCTGCTGACCCCCACTGATA and 3′
ACAAGAGCAGTGAGCGCTGAA for TGFβ; 5′AT-
GCCACCAAAGTGAGAACGTT and 3'CTCACCT-
CAGTGTGCGTTCTG for CTGF; 5′GGCGGCCA
GGGCTCCGACCC and 3′ AATTCCTGGTCT-
GGGGCACC for COLⅠ; 5′TGGTGTTGGAGCC-
GCTGCCA and 3′ CTCA GCACTA GAA TCT-
GTCC for COL Ⅲ; 5′ ATCATCAGCAAT-
GCCTCCTG and 3′ CCCTCCGACGCCTGCTT
for GAPDH. All data were expressed as the relative dif-
ferences after normalization to GAPDH expression.
TGF-β1, phospho-Smad2/3, COL1A1 and COL3A1
expression in kidney tissues
After decapitation, renal tissue samples were lysed and
protein concentrations were determined. Equal
amount of protein from tissue homogenates was sepa-
rated on SDS-PAGE gels and transferred to nitrocellu-
lose membranes, membrane was incubated with prima-
ry antibodies against TGF-β1, phospho-Smad2/3,
COL1A1,COL3A1 (Cell Signaling Technology, Bever-
ly, MA,USA) overnight. And then incubated with
HRP-conjugated secondary antibody (Cell Signaling
Technology), for 1 h and visualized with enhanced che-
miluminescence system (ECL kit, Amersham Pharma-
cia, Little Chalfont, Buckinghamshire, UK). Mem-
branes then were re-probed with an antibody against
Smad2/3 and actin (Cell Signaling Technology) as an
indicator for equal loading of samples. Western blot-
ting data and density of blots were quantified by densi-
tometric analysis using National Institutes of Health
(NIH) image software (NIH, Bethesda, MD, USA).
Statistical analysis
All data were analyzed using SPSS 13.0 software (SPSS
Statistics, Chicago, IL, USA). Data are expressed as
mean ± standard deviation ( xˉ ± s). When P < 0.05,
the difference was considered to be statistically signifi-
cant. Multiple comparisons between the experimental
groups were performed by one-way analysis of variance
with a Tukey post hoc test.
RESULTS
General state and cardiac function changes in each
group
Eight weeks after surgery, all animals in the sham
group were alive and generally in good condition. In
the MI group, three died because of severe heart fail-
ure, the remaining mice were varying degrees of short-
ness of breath, wheezing, eating and activity reduction.
Mice in the SM group also have a slight eating, re-
duced activity situation. The mice in the MI and SM
groups showed anatomical visible left ventricular cham-
ber and liver enlargement, lung congestion, pleural ef-
fusion and ascites. Transthoracic echocardiography re-
sults shown that cardiac infarction lead to LV enlarge-
ment and systolic dysfunction versus sham operated
mice (P < 0.05). When compared with the MI mice,
mice in the SM group had less LV enlargement (mea-
sured as LVDD and LVDS) and less LV systolic dys-
function (measured as EF and FS), MI also increased
SBP, while in the SM group decreased (Table 1). Our
data showed that the MI model documented the typi-
cal hemodynamic changes of chronic heart failure.
Renal injury and renal insufficiency in each group
Parameters of serum SCr and BUN could be used to
display the renal function in the renal disease. Eight
weeks after MI experimental model establishing, the
levels of SCr [(54.0 ± 8.7) μmol/L] and BUN [(20.9 ±
4.4) mmol/L] in MI group were higher than those of
the sham group for SCr [(49.6 ± 6.8) μmol/L] and
BUN [(18.4 ± 4.9) mmol/L] respectively (both P >
0.05). Treatment with Danshen slightly decreased the
levels of SCr [(52.6 ± 9.1) μmol/L] and BUN [(19.9 ±
Group
Sham
MI
SM
n
11
11
11
HR (times/min)
602.50±11.30
598.70±12.70
608.20±14.50
SBP (mm Hg)
100.30±1.70
119.10±2.30a
99.90±2.90b
IVS (mm)
0.95±0.02
0.92±0.01
0.90±0.01
LVDD (mm)
3.29±0.42
4.23±0.55a
3.91±0.53a
LVDS (mm)
1.68±0.31
3.59±0.52a
2.99±0.68a
FS (%)
42.31±5.09
19.65±3.42a
29.87±3.52a
EF (%)
88.91±6.42
59.16±4.73a
69.55±5.23a
Table 1 HR, SBP and echocardiography parameters of mice ( xˉ ± s)
Notes: sham: sham surgery group; MI: myocardial infarction group; SM: Danshen (Radix Salviae Miltiorrhizae) treatment group. The
Danshen (Radix Salviae Miltiorrhizae) treatment group were treated with 0.2 mL Danshen (Radix Salviae Miltiorrhizae) injection (each 10
mL vial contains active components equivalent to 15 g of the original medicine) intraperitoneally for 8 weeks. The sham group and myo-
cardial infarction group were treated with 0.2 mL saline injection intraperitoneally for 8 weeks. HR: heart rate; SBP: systolic blood pres-
sure; IVS: interventricular septum; LVDD: left ventricular end-diastolic diameter; LVDS: left ventricular end-systolic diameter; FS: frac-
tional shortening; EF: ejection fraction. aP < 0.05, vs sham group;bP < 0.05, vs MI group.
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8.5) mmol/L] compared with those of MI group, but
not signiﬁcantly (both P > 0.05). The 24 h urinary pro-
tein excretion was increased 8 weeks after MI model es-
tablishing from [(25.5 ± 0.7) mg/24 h] and Urinary al-
bumin [(17.7 ± 0.9) μg/24 h] to [(31.4 ± 0.9) mg/24 h]
and [(20.3 ± 5.4) μg/24 h]. Treatment with Danshen
could decrease the 24 h urinary protein excretion level
to [(29.3 ± 0.8) mg/24 h] and Urinary albumin [(18.9
± 3.5) μg/24 h], however, the data had no statistical
significance (both P > 0.05). These data displayed the
tendency of worsened renal function after MI, al-
though they had no statistical significance.
Renal pathological changes in each group
In the sham group, HE staining showed normal glo-
merular and tubular structures, renal tubular epithelial
cells arranged in neat rows and the stroma had no in-
flammatory cell infiltration. While in the MI group,
glomerular mesangial and tubular lumen expansion
and irregular thickening of the basement membrane
were observed, renal interstitial AZAN positive stain-
ing was significantly increased. These changes were sig-
nificantly reduced in the SM group (Figure 1).
Oxidative stress in the kidney
MDA and ROS are markers of oxidative stress, we
found that MDA and ROS values were significantly in-
crease after MI from (0.49 ± 0.09) to (1.89 ± 0.20)
nmol/mg protein and (88.32 ± 8.66) to (158.57 ±
18.65) μmol/mg protein respectively (both P < 0.05).
SM administration significantly decreased MDA and
ROS content to (1.53 ± 0.16) nmol/mg protein and
(101.58 ± 9.84) μmol/mg protein respectively (both
P < 0.05). SOD were investigated as the evaluation in-
dices of anti-oxidant enzyme activity. The SOD level
in the MI group [(199 ± 19) unit/mg protein] were sig-
niﬁcantly lower than that of control group [(249 ± 28)
unit/mg protein] (P < 0.05). With the treatment of
SM for 8 weeks, the levels of SOD [(225 ± 17) unit /
mg protein] were increased (P < 0.05). These data dis-
played the oxidative stress after MI, and SM treatment
represented favorable protection.
Fibrosis in kidney
The overproduction of interstitial matrix components
such as type Ⅰ and type Ⅲ collagen is thought to be
the most important event in renal fibrosis. To investi-
gate the fibrosis in kidney, we examined TGF-β, CT-
GF, COLⅠ and COLⅢ mRNA expression in the kid-
ney (Table 5). There were significantly increase in
TGF-β (1.49 ± 0.19) fold, CTGF (2.11 ± 0.10) fold,
COLⅠ (1.65 ± 0.11) fold and COLⅢ (1.47 ± 0.07)
fold expression in MI group compared with SHAM
group (P < 0.05). SM administration significantly de-
creased them (P < 0.05). To further investigate the sig-
nal pathway involved in the process of kidney fibrosis
after MI, we examined TGF-β1, phospho-Smad 2/3,
COL1A1 and COL3A1 expression in kidney tissues by
western blotting. The results showed that MI increased
TGF-β1, phospho-Smad 2/3, COL1A1 and COL3A1
expression, while SM administration significantly de-
creased them (P < 0.05). Our data indicated that
TGF-β/Smad pathway may be related with the devel-
opment of renal fibrosis in MI mice, and the anti-fibro-
sis effect of SM maybe due to the inhibition of TGF-β/
Smad pathway activation (Figure 2).
DISCUSSION
Reduced cardiac mass after MI commonly leads to con-
gestive heart failure in humans and in experimental ani-
mal models.19 In patients with congestive heart failure,
renal perfusion and function are often compromised,
which called cardiorenal syndrome.20,21 Cardiac and re-
nal dysfunctions often occur simultaneously because
FD E
A B C
Figure 1 Renal pathological changes of kidney sections in each group with HE and AZAN staining (× 200)
A, D: sham surgery group; B, E: myocardial infarction group; C, F: Danshen (Radix Salviae Miltiorrhizae) treatment group. A-C: HE
staining; D-F: AZAN staining. The Danshen (Radix Salviae Miltiorrhizae) treatment group were treated with 0.2 mL Danshen (Radix
Salviae Miltiorrhizae) injection (each 10 mL vial contains active components equivalent to 15 g of the original medicine) intraperi-
toneally for 8 weeks. The sham and myocardial infarction groups were treated with 0.2 mL saline injection intraperitoneally for 8
weeks. HE: hematoxylin-eosin; AZAN: azo-carmine G and aniline blue.
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they share causes and pathogenetic mechanisms. There
is a close association between renal and cardiac func-
tion in both acute and chronic diseaseCardiovascular
disease causes over 50% of deaths in patients with re-
nal failure while poor renal function increases mortali-
ty in patients with heart failure.22 Traditionally, renal
impairment has been attributed to the renal hypoperfu-
sion due to reduced cardiac output and decreased sys-
temic pressure. The hypovolemia leads to sympathetic
activity, increased renin-angiotensin-aldosterone path-
ways and arginine-vasopressin release. In addition, oxi-
dative stress are considered the main determinants of
both cardiac and renal dysfunction.23
Oxidative injury may contribute to the final pathway
of organ dysfunction. It is accepted that the produc-
tion of oxygen-derived radical species constitutes one
of the major events involved in the initiation, mainte-
nance and reversibility of functional alterations associ-
ated with ischemia injury.24, 25 It is known that myocar-
dial ischemia changes blood pressure.26 This situation
may causes damage in the highly perfusing organs such
as kidneys. Healthy kidneys consume relatively large
amounts of oxygen, accounting for approximately 10%
of total oxygen consumption by the body; thus, aber-
rant generation of ROS occurs prominently in the kid-
ney. In health, ROS generated by the kidneys are me-
tabolized by adaptive scavenger mechanisms. However,
in endogenous or exogenous renal injury, excessively
produced ROS may cause acute or progressive renal
damage.27 In this study we measured the activity of
SOD and the contents of MDA and ROS in the kid-
ney, which represented the oxidative injury of the or-
gan, and found that there were significantly increase in
MDA and ROS values and decrease in SOD activity af-
ter MI.
The model of coronary ligation in mouse was selected
since previous studies have documented the typical he-
modynamic changes of chronic heart failure,28 In the
present study, the left coronary artery of mice was oc-
cluded for 8 weeks, and the mice heart showed signifi-
cantly left ventricular enlargement and systolic dysfunc-
tion, accompanied with renal function presented as
slightly increased plasma BUN, SCr and urinary excre-
tion rate of protein and albumin concentration with
no statistical significance. AZAN staining results
showed glomerular fibrosis accompanied with in-
creased renal TGFβ,CTGF, phospho Smad2/3, COLⅠ and COLⅢ expression, which were consistent with
previous studies.
SM in the experiment, as an old Chinese herb, was
shown to be valuable for many kinds of disease previ-
ously. All these research reveal that SM play a role in
the treatment of some kind of disease by its prope rties
such as protect endothelial cells and prevent lipid per-
oxidation and calcium overload. SM were used in the
management of humans and experimental animals
with renal failure.29 In our study, we used the animal
model to mimic the cardiorenal syndrome in humans
both biochemically and morphologically. The charac-
teristic histological features of our models were find-
ings of swelling and necrosis of proximal or distal tu-
bules and edema of connective tissue in renal intersti-
tium. And the model also shown an increase in the se-
rum concentration of creatinine and BUN. In the
study, we are able to show a significant recovery of
mental state and progressive decrease of serum creati-
nine and BUN after SM administration. We have also
observed that SM attenuated the histologic severity of
kidney. So we can speculate on the mechanism underly-
ing the protective effect of SM on experimental MI in-
duced renal failure. It can improve the renal function
and prevent the oxidative stress in kidney tissue. How-
ever, there is still a great need for more and better re-
search on the efficacy and safety of SM. Although it is
difficult to extrapolate animal data to humans, we rec-
ommend SM as a beneficial treatment for MI induced
renal failure.
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